glp-1 and prostate cancer Receptor Agonists in Solid Tumour Therapy: Exploring Their Anticancer Potential Underlying Molecular Pathways Targeting obesity, metabolic syndrome, and

KEY OBSERVATIONS One large no-sweat ice pack wrapped in insulated foam kept the medication cold during transit

Pairing with oral supplements or medicated treatments may be necessary for more advanced or hormone-related hair loss

( Source ) The continued growth in uptake of GLP-1 agonists is uncertain

It is not safe for people who have: A seizure disorder or a history of seizures A history of anorexia or bulimia Opioid dependence or have recently used opioids Uncontrolled high blood pressure A history of suicidal thoughts or actions Are taking MAO inhibitors (certain antidepressants) Who should avoid each medication You should not use Ozempic if you: Are allergic to semaglutide or any of the ingredients Have a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2) Are pregnant or planning to become pregnant Are breastfeeding, as it is not known if Ozempic passes into breast milk

Tirzepatide with glycine follows the same stabilization rationale, and tirzepatide with B12 helps offset the energy dips that some patients experience during the first few weeks of treatment

Future research should evaluate the impact of GLP-1 RAs on long-term clinical outcomes, such as cardiovascular mortality and hospitalizations for heart failure